Emerging evidence suggests that red blood cell (RBC)-CD163-hemoglobin (Hb) recycling pathways are associated with metabolic disorder such as NAFLD [2,3,4]. This evidence concerns the gene GSTM1 and metabolic dysfunction-associated steatotic liver disease.